| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c9ae1a0af7059b6d1c45022d94722710
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ea7e3ddbe770ae4634d6edec93ac715d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2207-30096
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2207-10088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2576-02 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-7485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-7275
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T7-0014 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06T7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-055 |
| filingDate |
2017-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_957b3f9f3bfdf4ee03d8addc463b816a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_794c53d9ab1fb47e8ac03d14a86834ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6431498778d4777c32569fda1bd8c1a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29f104fdde8cb367c26545c55ab10a9f |
| publicationDate |
2019-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2019156479-A1 |
| titleOfInvention |
Processing mri data for analysis of tumors |
| abstract |
Dynamic contrast enhanced MRI data and dynamic susceptibility contrast MRI data for a volume of the patient's body including a tumor are used in order to identify the risk of lymph node metastasis. A volume of interest enclosing the tumor is identified and the MRI data for the volume of interest is processed in order to identify one or more parameters relating to the transverse relaxation rate and/or to dynamic changes in the transverse relaxation rate. A comparison is made to previously obtained similar parameters for other patients having similar tumors that are either known to exhibit lymph node metastasis or are known not to exhibit lymph node metastasis in order to determine if the MRI data indicates that the patient has a tumor at greater risk of exhibiting lymph node metastasis or a tumor with a lesser risk of exhibiting lymph node metastasis. |
| priorityDate |
2016-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |